Drug recall · April 30, 2014
VPRIV¿ (velaglucerase alfa for injection) recall
Why: Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.
- Lots / codes
US: Lot #: FEW13-001, FEW13-002, FED13-006; Expiry: 10/15. Mexico: Lot #: FED 013-010; Expiry: 10/15. Columbia: Lot #: FED 013-011; Expiry: 10/15.
- Quantity
- 8359 vials
- Company
- Shire Human Genetic Therapies, Inc., Lexington, MA
- Distribution
- US Nationwide including Puerto Rico; Mexico, Columbia
- Initiated
- March 14, 2014 · Voluntary: Firm initiated
- Classified
- April 18, 2014
- Reported
- April 30, 2014
- Ended
- August 31, 2016
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.